Healthy volunteers test new drug AJ302-IM for safety
Knowledge-focused
Completed
This early-stage study tested a single dose of AJ302-IM in 57 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo by injection. The goal was to check for side effects and measure drug levels in the blood, not to tr…
Phase: PHASE1 • Sponsor: AnnJi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 11:51 UTC